Citation only
via Europe PMC
Decode the Ubiquitinome in Parkinson's Disease: From Pathological Aggregates to Targeted DUB Therapeutics.
Yu X, Ni Q, Han L, Zhang S, Xu H, Xie J, Liu Y.
Neuroscience bulletin · 2026 · ▲ 1 citations
Loss of proteostasis
Mitochondrial dysfunction
Altered intercellular communication
Chronic inflammation
Disabled macroautophagy
Review
Abstract
Parkinson's disease (PD), a neurodegenerative disorder, is significantly influenced by genetic predispositions, aging, and environmental factors. Central to PD pathology are mechanisms such as aberrant α-synuclein aggregation, mitochondrial dysfunction(definition), oxidative stress, neuroinflammation, and ferroptosis, all of which are closely associated with dysregulated protein post-translational modifications. Ubiquitination, a critical reversible modification, acts as a pivotal bridge connecting the ubiquitin-proteasome system and the lysosomal-autophagy(definition) pathway, with its dynamics finely counterbalanced by deubiquitinating enzymes (DUBs). Notably, under pathological conditions, many DUBs exacerbate disease by stabilizing toxic α-syn aggregates and suppressing mitophagy. This review synthesizes current knowledge on how ubiquitin signaling orchestrates PD pathogenesis and highlights the emerging therapeutic potential of targeting specific DUBs with small molecule inhibitors to restore proteostasis(definition) and mitochondrial quality control, offering novel strategies for disease modification in PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s12264-026-01613-6
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
X, Y., Q, N., L, H., S, Z., H, X., J, X., & Y., L. (2026). Decode the Ubiquitinome in Parkinson's Disease: From Pathological Aggregates to Targeted DUB Therapeutics. <em>Neuroscience bulletin</em>. https://doi.org/10.1007/s12264-026-01613-6
Vancouver
X Y, Q N, L H, S Z, H X, J X, et al. Decode the Ubiquitinome in Parkinson's Disease: From Pathological Aggregates to Targeted DUB Therapeutics. Neuroscience bulletin. 2026. doi:10.1007/s12264-026-01613-6.
BibTeX
@article{yu2026Decode,
title = {Decode the Ubiquitinome in Parkinson's Disease: From Pathological Aggregates to Targeted DUB Therapeutics.},
author = {Yu X and Ni Q and Han L and Zhang S and Xu H and Xie J and Liu Y.},
journal = {Neuroscience bulletin},
year = {2026},
doi = {10.1007/s12264-026-01613-6},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Applied Sciences 2025
Open access · CC-BY
Exploring Protein Misfolding and Aggregate Pathology in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Interventions
Frontiers in Cell and Developmental Biology 2021
Open access · CC-BY
PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
Frontiers in Cellular Neuroscience 2020
Open access · CC-BY
Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson’s Disease
Cellular and Molecular Neurobiology 2025
Open access · CC-BY
Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson’s Disease
Cells 2025
Open access · CC-BY
Mitochondrial Dysfunction in Neurodegenerative Diseases
Oxidative Medicine and Cellular Longevity 2020
Open access · CC-BY